{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:35:42Z","timestamp":1776818142718,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jbc.2026.111341","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:19:19Z","timestamp":1772641159000},"page":"111341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PLLP inhibits the progression of WT p53 gastric cancer by reducing p53 protein ubiquitination by binding to TRIM59"],"prefix":"10.1016","volume":"302","author":[{"given":"Zhenhao","family":"Quan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caijin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2934-6409","authenticated-orcid":false,"given":"Haiping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111341_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103841","article-title":"Characteristics of gastric cancer around the world","volume":"181","author":"L\u00f3pez","year":"2023","journal-title":"Crit. Rev. Oncol Hematol"},{"key":"10.1016\/j.jbc.2026.111341_bib2","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cam4.4586","article-title":"Gastric and esophageal cancer in China 2000 to 2030: Recent trends and short-term predictions of the future burden","volume":"11","author":"Zhou","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.jbc.2026.111341_bib3","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.111341_bib4","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.111341_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.jbc.2026.111341_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.111341_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1134\/S0026893321050113","article-title":"Plasmolipin and its role in cell processes","volume":"55","author":"Shulgin","year":"2021","journal-title":"Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111341_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00018-021-04095-z","article-title":"Plasmolipin regulates basolateral-to-apical transcytosis of ICAM-1 and leukocyte adhesion in polarized hepatic epithelial cells","volume":"79","author":"Cacho-Navas","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jbc.2026.111341_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.cdd.4402083","article-title":"Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation","volume":"14","author":"Kim","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2026.111341_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.gastro.2014.07.021","article-title":"TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53","volume":"147","author":"Zhou","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbc.2026.111341_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cell.2007.02.022","article-title":"Wild-type p53: tumors can't stand it","volume":"128","author":"Kastan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111341_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026245","article-title":"Targeting the MDM2-p53 protein-protein interaction for new cancer therapy: progress and challenges","volume":"7","author":"Wang","year":"2017","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.jbc.2026.111341_bib13","first-page":"5762","article-title":"Therapeutic opportunities in cancer therapy: targeting the p53-MDM2\/MDMX interactions","volume":"11","author":"Munisamy","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111341_bib14","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.928375","article-title":"Silencing ribosomal protein L22 promotes proliferation and migration, and inhibits apoptosis of gastric cancer cells by regulating the murine double minute 2-Protein 53 (MDM2-p53) signaling pathway","volume":"27","author":"Sun","year":"2021","journal-title":"Med. Sci. Monitor"},{"key":"10.1016\/j.jbc.2026.111341_bib15","first-page":"92","article-title":"Targeting p53 pathways: mechanisms, structures, and","volume":"8","author":"Wang","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jbc.2026.111341_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2026.111341_bib17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","article-title":"Integrated analysis of TP53 gene and pathway alterations in the cancer genome Atlas","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111341_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.jbc.2026.111341_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114989","article-title":"Cellular senescence signaling in cancer: a novel therapeutic target to combat human malignancies","volume":"199","author":"Fakhri","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111341_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/cdd.2017.171","article-title":"Deconstructing networks of p53-mediated tumor suppression in vivo","volume":"25","author":"Kaiser","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2026.111341_bib21","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1158\/1078-0432.CCR-07-5136","article-title":"Targeting the MDM2-p53 interaction for cancer therapy","volume":"14","author":"Shangary","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111341_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MOH.0000000000000715","article-title":"Role of p53 in regulation of hematopoiesis in health and disease","volume":"29","author":"Barajas","year":"2022","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jbc.2026.111341_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.111341_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41401-022-00973-9","article-title":"p52-ZER6: a determinant of tumor cell sensitivity to MDM2-p53 binding inhibitors","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jbc.2026.111341_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1208\/s12248-020-00551-z","article-title":"Translational Modeling of Anticancer Efficacy to Predict Clinical Outcomes in a First-in-Human Phase 1 Study of MDM2 Inhibitor HDM201","volume":"23","author":"Guerreiro","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.jbc.2026.111341_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jbc.2026.111341_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70058","article-title":"Eugenol Alleviates Cerebral Ischemia-Reperfusion Injury in Mice by Promoting the Phagocytosis of Microglia via Up-Regulating Tripartite Motif Protein 59","volume":"137","author":"Pan","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jbc.2026.111341_bib28","article-title":"Prognostic significance of TRIM59 for cancer patient survival: a systematic review and meta-analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jbc.2026.111341_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026868","article-title":"Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis","volume":"100","author":"Guo","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbc.2026.111341_bib30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.devcel.2024.06.014","article-title":"E3 ubiquitin ligase IPI1 controls rice immunity and flowering via both E3 ligase-dependent and -independent pathways","volume":"59","author":"Yi","year":"2024","journal-title":"Develop. Cel."},{"key":"10.1016\/j.jbc.2026.111341_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:36:47Z","timestamp":1776814607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826002115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0021925826002115"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111341","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLLP inhibits the progression of WT p53 gastric cancer by reducing p53 protein ubiquitination by binding to TRIM59","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111341"}}